The incidence of positive margins with breast conserving therapy following mammotome biopsy for microcalcification
Cangiarella, J.; Cross, J.; Symmans, W. F.; Waisman, J.; Petersen, B.; D'Angelo, D.; Singer, C., and Axelrod, D.. Journal of Surgical Oncology. 74(4):263-266, 2000 Aug.

Outcomes and factors impacting local recurrence of ductal carcinoma in situ.
Weng, E. Y.; Juillard, G. J. F.; Parker, R. G.; Chang, H. R., and Gornbein, J. A. Cancer. 88(7):1643-1649, 2000 Apr 1.

Risk of subsequent invasive breast cancer after breast carcinoma in situ
Warnberg, F.; Yuen, J., and Holmberg, L. (Reprint available from: Warnberg F Univ Uppsala Hosp, Dept Surg S-75185 Uppsala Sweden).. Lancet. 355(9205):724-725, 2000 Feb 26.

Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy
Vicini, F. A.; Kestin, L. L.; Goldstein, N. S.; Chen, P. Y.; Pettinga, J.; Frazier, R. C., and Martinez, A. A.. Journal of Clinical Oncology. 18(2):296-306, 2000 Jan.

Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas, S.; Dauway, E.; Giuliano, R.; Ku, N. N.; Cox, C. E., and Reintgen, D. S.. Annals of Surgical Oncology. 7(1):15-20, 2000 Jan-Feb.

Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
Ottesen, G. L.; Christensen, I. J.; Larsen, J. K.; Larsen, J.; Baldetorp, B.; Linden, T.; Hansen, B., and Andersen, J. (Reprint available from: Ottesen GL Univ Copenhagen, Inst Forens Med, Dept Forens Pathol Frederik Vs Vej 11,POB 2713 DK-2100 Copenhagen O Denmark).. Breast Cancer Research & Treatment. 60(3):219-226, 2000 Apr In process

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853.
Julien, J. P.; Bijker, N.; Fentiman, I. S.; Peterse, J. L.; Delledonne, V.; Rouanet, P.; Avril, A.; Sylvester, R.; Mignolet, F.; Bartelink, H., and Van Dongen, J. A. Lancet. 355(9203):528-533, 2000 Feb 12.

Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.
Goldstein, N. S.; Vicini, F. A.; Kestin, L. L., and Thomas, M.. Cancer. 88(11):2553-2560, 2000 Jun 1.

Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examinated by serial macroscopic sectioning: Practical considerations.
de Mascarel, I.; Bonichon, F.; MacGrogan, G.; de Lara, C. T.; Avril, A.; Picot, V.; Durand, M.; Mauriac, L.; Trojani, M., and Coindre, J. M. Breast Cancer Research & Treatment. 61(2):151-159, 2000 May.

Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
Kestin, L. L.; Goldstein, N. S.; Lacerna, M. D.; Balasubramaniam, M.; Martinez, A. A.; Rebner, M.; Pettinga, J.; Frazier, R. C., and Vicini, F. A.. Cancer. 88(3):596-607, 2000 Feb 1.

Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast.
Waddell, B. E.; Stomper, P. C.; DeFazio, J. L.; Hurd, T. C., and Edge, S. B. Annals of Surgical Oncology. 7(9):665-668, 2000 Oct.

Ductal carcinoma in situ of the breast: A surgeon's disease.
Silverstein, M. J. (Reprint available from: Silverstein MJ Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr 1441 Eastlake Ave,Room 7415 Los Angeles, CA 90033 USA). Annals of Surgical Oncology. 6(8):802-810, 1999 Dec. No abstract

Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast.
Rubio, I. T.; Mirza, N.; Sahin, A. A.; Whitman, G.; Kroll, S. S.; Ames, F. C., and Singletary, S. E. Annals of Surgical Oncology. 7(7):544-548, 2000 Aug

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
Ottesen, G. L.; Graversen, H. P.; Blichert-Toft, M.; Christensen, I. J., and Andersen, J. A. (Reprint available from: Ottesen GL Univ Copenhagen, Inst Forens Med, Dept Forens Pathol Frederik Vs Vej 11,POB 2713 DK-2100 Copenhagen Denmark).. Breast Cancer Research & Treatment. 62(3):197-210, 2000 Aug

Treatment selection in ductal carcinoma in situ.
Morrow, M. and Schnitt, S. J. (Reprint available from: Morrow M NW Mem Hosp, Lynn Sage Comprehens Breast Ctr 251 E Huron St,Galter 13-174 Chicago, IL 60611 USA).. Jama: Journal of the American Medical Association. 283(4):453-455, 2000 Jan 26. No abstract

Outcomes and factors impacting local recurrence of ductal carcinoma in situ.
Lagios, M. D. and Silverstein, M. J. (Reprint available from: Lagios MD St Marys Med Ctr, Breast Canc Consultat Serv San Francisco, CA 94143 USA).. Cancer. 89(11):2323-2324, 2000 Dec 1. In process

Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
Klauber-DeMore, N.; Tan, L. K.; Liberman, L.; Kaptain, S.; Fey, J.; Borgen, P.; Heerdt, A.; Montgomery, L.; Paglia, M.; Petrek, J. A.; Cody, H. S., and Van Zee, K. J. Annals of Surgical Oncology. 7(9):636-642, 2000 Oct.

Relation of a recurrent intraductal carcinoma (ductal carcinoma in situ) to the primary tumor Fisher, E. R. and Fisher, B. (Reprint available from: Fisher B NSABP Sci Directors Off 4 Allegheny Ctr,Suite 602 Pittsburgh, PA 15212 USA).. Journal of the National Cancer Institute. 92(4):288-289, 2000 Feb 16. No abstract

Top of Page